Claudio Umberto Köser

27PUBLICATIONS
84CO-AUTHORS
Disease surveillanceMedical infection agents (incl. prions)Medical bacteriologyBacteriologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 26, 2026
Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

|Sep 22, 2025
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders

|Apr 22, 2025
The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.

Viktória Szél, Jody E Phelan, Sophia B Georghiou

|Mar 14, 2024
The exceptions that prove the rule-a historical view of bedaquiline susceptibility.

Paolo Miotto, Daniela M Cirillo, Thomas Schön

|Feb 09, 2024
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid.

Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken

|Dec 01, 2023
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis.

Sushil Pandey, Catherine Vilchèze, Jim Werngren

Pageof 5

Frequent Collaborators

10 joint publications

Daniela Maria Cirillo

9 joint publications

Paolo Miotto

8 joint publications

Julian Parkhill

4 joint publications

Stefan Niemann